JPM vs TFC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
TFC presents a compelling value opportunity, trading significantly below its Graham Number ($64.06) and Intrinsic Value ($88.62). While the Piotroski F-Score of 4/9 indicates only stable financial health and technical trends are currently bearish, the fundamental valuation metrics (P/E of 12.94 and P/B of 1.04) are highly attractive. Strong year-over-year earnings growth of 23.1% and a sustainable 4.21% dividend yield provide a solid floor for investors. The disconnect between the deep value and the bearish insider/technical signals suggests a potential contrarian entry point.
Compare Another Pair
Related Comparisons
JPM vs TFC: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Truist Financial Corporation (TFC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.